Gynesonics, Inc., a women's healthcare company focused on the
development of minimally invasive solutions for symptomatic uterine
fibroids, today announced it has named veteran medical device executive
Richard P. Lanigan as Vice President, Global Commercialization,
effective immediately. Lanigan reports directly to President and CEO
Christopher M. Owens. Gynesonics recently received CE Mark approval to
market its newly-designed VizAblate® System in the European Union. The
VizAblate System, which provides an incision-free approach for the
treatment of symptomatic fibroids, offers a distinct alternative to
Lanigan, 55, a resident of San Juan Capistrano, CA, has 23 years of
medical device experience that included executive commercial roles and
senior management responsibilities on a global basis. Most recently, in
2013, he served as a global commercial operations consultant for
Webster, TX-based IDEV Technologies, a privately-held developer of
endovascular technologies in the periperal vascular market that was
acquired by Abbott Vascular in 2013.
"Rich has a wide range of experience in business and clinical
development, reimbursement, and global product commercialization, as
well as the drive and passion to assist Gynesonics at this critical
stage of our growth," Owens said. "One of our most immediate goals as a
management team is to progress through the next steps in the clinical
validation and initial targeted commercialization of our unique and
nonsurgical VizAblate® System for symptomatic uterine fibroids. Rich
will take a leadership role in that effort and we are excited to have
him on our team."
Prior to IDEV, Lanigan was General Manager at Irvine, CA-based Synovis
Orthopedic & Woundcare Inc., a division of St. Paul, MN-based Synovis
Life Technologies Inc., during 2011-2012, which was acquired by Baxter
International in 2012. Before that he spent 10 years, from 2001-2011, in
positions of increasing responsibility and ultimately became a corporate
officer and acting President at Irvine, CA-based Cardiogenesis Corp.,
which was purchased by CryoLife in 2011.
Lanigan earned a bachelor's degree in business administration from the
University of Notre Dame and a Masters of Science degree in systems
management from the University of Southern California. He also served
for six years in the U.S. Navy, attaining the rank of Lieutenant.
Gynesonics is a women's healthcare company focused on minimally invasive
solutions for symptomatic uterine fibroids. Gynesonics has developed the
VizAblate® System for the transcervical treatment of
symptomatic uterine fibroids under intrauterine ultrasound guidance.
VizAblate has received CE Mark approval for commercial sale in the
European Union. VizAblate is not available for sale in the United
States. Gynesonics is a privately held company with headquarters in
Redwood City, CA.
[ Back To NFVZone's Homepage ]